EDISON, N.J., June 1 /PRNewswire-FirstCall/ -- Konsyl Pharmaceuticals, Inc. announced today the introduction of SennaPrompt(TM), the only natural fiber therapy for predictable overnight relief for constipation. Unlike fiber-only products, SennaPrompt(TM) contains natural sennosides for dependable relief within 12 hours. Each capsule of SennaPrompt(TM) contains 500mg of Psyllium and 9mg of Sennosides uniquely providing a rich source of natural fiber and a fast start to a healthy fiber therapy regimen.
SennaPrompt(TM) offers a unique combination of bulking agent and stimulant, no sugar or sugar substitutes, 0 mgs of sodium, only 10 calories, safe for diabetics and only 2 grams of carbohydrates.
According to Anthony Cantaffa, President of Konsyl, "SennaPrompt(TM) is a unique product that will provide a platform for Konsyl to build on and introduce other new branded colon health care products."
SennaPrompt(TM) began shipping nationwide to retailers and distributors on May 18. A national television, print, and radio campaign, along with a strong promotion program geared to consumers and medical professionals, will begin in September.
Konsyl is a manufacturer and distributor of powdered natural fiber dietary supplements, which has been in business over 35 years. The products are manufactured at their plant in Easton, Maryland and are sold, both domestically and internationally, to pharmaceutical wholesalers, drugstore chains, mass merchandisers, grocery store chains, and grocery distributors. Products are sold under both the "Konsyl(R)" brand name and various private labels. The "Konsyl(R)" brand product line and private label products are generally merchandised in pharmacy sections along with other bulk forming laxatives. Konsyl also manufactures a gastrointestinal diagnostic product, "Sitzmarks", that is sold to hospitals, colon and rectal surgeons, and radiologists. Konsyl was acquired by Pharmaceutical Formulations, Inc. (PFI) on May 15, 2003.
Founded in 1964, Pharmaceutical Formulations, Inc., (BULLETIN BOARD: PHFR) is a publicly-traded private label manufacturer and distributor of OTC solid dose pharmaceutical products sold in the United States, and powdered, natural fiber dietary supplements which are sold in the United States and overseas.
ICC Industries Inc. is the holder of approximately 74.5 million shares (about 87%) of the common stock of PFI. ICC is a global leader in the manufacturing, marketing and trading of chemical, plastic and pharmaceutical products. Founded as a trading enterprise in 1952, ICC has grown to include manufacturing, with production facilities in the United States, Europe, the Middle East and Asia.
Pharmaceutical Formulations, Inc.